Prognosticators and Risk Grouping in Patients with Lung Metastasis from Nasopharyngeal Carcinoma: A more accurate and appropriate assessment of prognosis

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Cao, Xun ^a,b   Luo, Rong Zhen ^a,b   He, Li Ru ^a,b   Li, Yong ^a,b   Lin, Wen Qian ^a,b   Chen, You Fang ^a,b   Wen, Zhe Sheng ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Lung metastasis; Nasopharyngeal carcinoma; Prognosis; Risk subset

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGE; AGED; ANTIBODY TITER; ARTICLE; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER SURVIVAL; DISEASE FREE INTERVAL; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; DISEASE FREE SURVIVAL; LUNG TUMOR; METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNX TUMOR; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; RISK; TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK; TIME FACTORS; TREATMENT OUTCOME;

EID: 80052028890     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-104     Document Type: Article

References (41)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108. 10.3322/canjclin.55.2.74, 15761078.
3. Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet 2005, 365:2041-2054. 10.1016/S0140-6736(05)66698-6, 15950718.
4. Marks JE, Phillips JL, Menck HR. The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer 1998, 83:582-588. 10.1002/(SICI)1097-0142(19980801)83:3<582::AID-CNCR29>3.0.CO;2-R, 9690553.
5. Lee AW, Sze WM, Au JS, Leung SF, Leung TW, Chua DT, Zee BC, Law SC, Teo PM, Tung SY, et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 2005, 61:1107-1116. 10.1016/j.ijrobp.2004.07.702, 15752890.
6. Ng WT, Lee MC, Hung WM, Choi CW, Lee KC, Chan OS, Lee AW. Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2011, 79:420-428. 10.1016/j.ijrobp.2009.11.024, 20452132.
7. Fandi A, Bachouchi M, Azli N, Taamma A, Boussen H, Wibault P, Eschwege F, Armand JP, Simon J, Cvitkovic E. Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type. J Clin Oncol 2000, 18:1324-1330.
8. Hui EP, Leung SF, Au JS, Zee B, Tung S, Chua D, Sze WM, Law CK, Leung TW, Chan AT. Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Cancer 2004, 101:300-306. 10.1002/cncr.20358, 15241827.
9. Teo PM, Kwan WH, Lee WY, Leung SF, Johnson PJ. Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer 1996, 77:2423-2431. 10.1002/(SICI)1097-0142(19960615)77:12<2423::AID-CNCR2>3.0.CO;2-N, 8640688.
10. Wolff HA, Rodel RM, Gunawan B, Overbeck T, Herrmann MK, Hennies S, Hille A, Vorwerk H, Matthias C, Hess CF, Christiansen H. Nasopharyngeal carcinoma in adults: treatment results after long-term follow-up with special reference to adjuvant interferon-beta in undifferentiated carcinomas. J Cancer Res Clin Oncol 2010, 136:89-97. 10.1007/s00432-009-0640-2, 2779341, 19618214.
11. Khanfir A, Frikha M, Ghorbel A, Karray H, Drira MM, Daoud J. [Metastatic nasopharyngeal carcinoma: clinical study and therapeutic results of 95 cases]. Cancer Radiother 2006, 10:545-549.
12. Ong YK, Heng DM, Chung B, Leong SS, Wee J, Fong KW, Tan T, Tan EH. Design of a prognostic index score for metastatic nasopharyngeal carcinoma. Eur J Cancer 2003, 39:1535-1541. 10.1016/S0959-8049(03)00310-1, 12855259.
13. Winter H, Meimarakis G, Hoffmann G, Hummel M, Ruttinger D, Zilbauer A, Stelter K, Spelsberg F, Jauch KW, Hatz R, Lohe F. Does surgical resection of pulmonary metastases of head and neck cancer improve survival?. Ann Surg Oncol 2008, 15:2915-2926. 10.1245/s10434-008-0001-4, 18648883.
14. Cheng LC, Sham JS, Chiu CS, Fu KH, Lee JW, Mok CK. Surgical resection of pulmonary metastases from nasopharyngeal carcinoma. Aust N Z J Surg 1996, 66:71-73. 10.1111/j.1445-2197.1996.tb01114.x, 8602817.
15. Ma J, Wen ZS, Lin P, Wang X, Xie FY. [The results and prognosis of different treatment modalities for solitary metastatic lung tumor from nasopharyngeal carcinoma: a retrospective study of 105 cases]. Chin J Cancer 2010, 29:787-795.
16. Leong PP, Rezai B, Koch WM, Reed A, Eisele D, Lee DJ, Sidransky D, Jen J, Westra WH. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst 1998, 90:972-977. 10.1093/jnci/90.13.972, 9665144.
17. Shepherd MP. Thoracic metastases. Thorax 1982, 37:366-370. 10.1136/thx.37.5.366, 459318, 7112473.
18. Askin FB. Something old? Something new? Second primary or pulmonary metastasis in the patient with known extrathoracic carcinoma. Am J Clin Pathol 1993, 100:4-5.
19. Vyas JJ, Desai PB, Rao ND. Exploratory thoracotomy on a patient with previous malignancy--"metastasis" or "new primary" or "unrelated lesion". J Surg Oncol 1981, 18:281-286. 10.1002/jso.2930180310, 7311556.
20. Adkins PC, Wesselhoeft CW, Newman W, Blades B. Thoracotomy on the patient with previous malignancy: metastasis or new primary?. J Thorac Cardiovasc Surg 1968, 56:351-361.
21. Husband JE, Reznek RH. Imaging in oncology 2004, London: Taylor & Francis, 2.
22. Buthiau D, Khayat D. CT and MRI in oncology 1998, Berlin; London: Springer.
23. Lin JC, Jan JS, Hsu CY, Liang WM, Jiang RS, Wang WY. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol 2003, 21:631-637. 10.1200/JCO.2003.06.158, 12586799.
24. Chan AT, Leung SF, Ngan RK, Teo PM, Lau WH, Kwan WH, Hui EP, Yiu HY, Yeo W, Cheung FY, et al. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 2005, 97:536-539. 10.1093/jnci/dji084, 15812080.
25. Chan AT, Teo PM, Ngan RK, Leung TW, Lau WH, Zee B, Leung SF, Cheung FY, Yeo W, Yiu HH, et al. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol 2002, 20:2038-2044. 10.1200/JCO.2002.08.149, 11956263.
26. Lee AW, Tung SY, Chua DT, Ngan RK, Chappell R, Tung R, Siu L, Ng WT, Sze WK, Au GK, et al. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 2010, 102:1188-1198. 10.1093/jnci/djq258, 20634482.
27. Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, Bosch W, Morrison WH, Quivey J, Thorstad W, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol 2009, 27:3684-3690. 10.1200/JCO.2008.19.9109, 2720082, 19564532.
28. Kwan WH, Teo PM, Chow LT, Choi PH, Johnson PJ. Nasopharyngeal carcinoma with metastatic disease to mediastinal and hilar lymph nodes: an indication for more aggressive treatment. Clin Oncol (R Coll Radiol) 1996, 8:55-58.
29. Perez CA, Devineni VR, Marcial-Vega V, Marks JE, Simpson JR, Kucik N. Carcinoma of the nasopharynx: factors affecting prognosis. Int J Radiat Oncol Biol Phys 1992, 23:271-280. 10.1016/0360-3016(92)90741-Y, 1587746.
30. Kwong D, Sham J, Choy D. The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: an analysis of 1301 patients. Int J Radiat Oncol Biol Phys 1994, 30:1029-1036.
31. Chua DT, Sham JS, Kwong DL, Choy DT, Au GK, Wu PM. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma. A significant factor in local control and distant metastasis. Cancer 1996, 78:202-210. 10.1002/(SICI)1097-0142(19960715)78:2<202::AID-CNCR3>3.0.CO;2-N, 8673993.
32. Geara FB, Sanguineti G, Tucker SL, Garden AS, Ang KK, Morrison WH, Peters LJ. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival. Radiother Oncol 1997, 43:53-61. 10.1016/S0167-8140(97)01914-2, 9165137.
33. Cheng SH, Yen KL, Jian JJ, Tsai SY, Chu NM, Leu SY, Chan KY, Tan TD, Cheng JC, Hsieh CY, Huang AT. Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials. Int J Radiat Oncol Biol Phys 2001, 50:717-726. 10.1016/S0360-3016(01)01509-7, 11395240.
34. Khanfir A, Frikha M, Ghorbel A, Drira MM, Daoud J. Prognostic factors in metastatic nasopharyngeal carcinoma. Cancer Radiother 2007, 11:461-464.
35. Leibel SA, Scott CB, Mohiuddin M, Marcial VA, Coia LR, Davis LW, Fuks Z. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys 1991, 21:549-556. 10.1016/0360-3016(91)90669-U, 1869453.
36. Razak AR, Siu LL, Liu FF, Ito E, O'Sullivan B, Chan K. Nasopharyngeal carcinoma: the next challenges. Eur J Cancer 2010, 46:1967-1978. 10.1016/j.ejca.2010.04.004, 20451372.
37. Chien YC, Chen JY, Liu MY, Yang HI, Hsu MM, Chen CJ, Yang CS. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med 2001, 345:1877-1882. 10.1056/NEJMoa011610, 11756578.
38. Liu MT, Yeh CY. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC). Radiat Med 1998, 16:113-117.
39. Mountain CF, McMurtrey MJ, Hermes KE. Surgery for pulmonary metastasis: a 20-year experience. Ann Thorac Surg 1984, 38:323-330. 10.1016/S0003-4975(10)62280-1, 6486949.
40. Morrow CE, Vassilopoulos PP, Grage TB. Surgical resection for metastatic neoplasms of the lung: experience at the University of Minnesota Hospitals. Cancer 1980, 45:2981-2985. 10.1002/1097-0142(19800615)45:12<2981::AID-CNCR2820451216>3.0.CO;2-N, 6155986.
41. Nibu K, Nakagawa K, Kamata S, Kawabata K, Nakamizo M, Nigauri T, Hoki K. Surgical treatment for pulmonary metastases of squamous cell carcinoma of the head and neck. Am J Otolaryngol 1997, 18:391-395. 10.1016/S0196-0709(97)90059-4, 9395015.